These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 17077652

  • 1. Ophthalmic cyclosporine use in ocular GVHD.
    Lelli GJ, Musch DC, Gupta A, Farjo QA, Nairus TM, Mian SI.
    Cornea; 2006 Jul; 25(6):635-8. PubMed ID: 17077652
    [Abstract] [Full Text] [Related]

  • 2. Topical cyclosporine-A in dry eye associated with chronic graft versus host disease.
    Kurt RA, Yalçindag N, Atilla H, Arat M.
    Ann Ophthalmol (Skokie); 2009 Jul; 41(3-4):166-9. PubMed ID: 20214049
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.
    Rao SN, Rao RD.
    Cornea; 2006 Jul; 25(6):674-8. PubMed ID: 17077659
    [Abstract] [Full Text] [Related]

  • 4. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
    Wang Y, Ogawa Y, Dogru M, Kawai M, Tatematsu Y, Uchino M, Okada N, Igarashi A, Kujira A, Fujishima H, Okamoto S, Shimazaki J, Tsubota K.
    Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
    [Abstract] [Full Text] [Related]

  • 5. Treatment of ocular graft-versus-host disease with topical cyclosporine 0.05%.
    Malta JB, Soong HK, Shtein RM, Musch DC, Rhoades W, Sugar A, Mian SI.
    Cornea; 2010 Dec; 29(12):1392-6. PubMed ID: 20847658
    [Abstract] [Full Text] [Related]

  • 6. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.
    Wilson SE, Perry HD.
    Ophthalmology; 2007 Jan; 114(1):76-9. PubMed ID: 17070588
    [Abstract] [Full Text] [Related]

  • 7. Dry-eye syndrome after allogeneic stem-cell transplantation in children.
    Fahnehjelm KT, Törnquist AL, Winiarski J.
    Acta Ophthalmol; 2008 May; 86(3):253-8. PubMed ID: 18093259
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of cyclosporine 0.05% ophthalmic emulsion for contact lens-intolerant patients.
    Hom MM.
    Eye Contact Lens; 2006 Mar; 32(2):109-11. PubMed ID: 16538135
    [Abstract] [Full Text] [Related]

  • 10. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD, Pflugfelder SC, Tauber J, Foulks GN.
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [A 0,05% cyclosporine treatment of the advanced dry eye syndrome].
    Kujawa A, Rózycki R.
    Klin Oczna; 2005 Oct; 107(4-6):280-6. PubMed ID: 16118939
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical and economic implications of topical cyclosporin A for the treatment of dry eye.
    Cross WD, Lay LF, Walt JG, Kozma CM.
    Manag Care Interface; 2002 Sep; 15(9):44-9. PubMed ID: 12244650
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dry eye symptoms following cataract surgery.
    Roberts CW, Elie ER.
    Insight; 2007 Sep; 32(1):14-21; quiz 22-3. PubMed ID: 17533782
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Topical cyclosporine a treatment in corneal refractive surgery and patients with dry eye.
    Torricelli AA, Santhiago MR, Wilson SE.
    J Refract Surg; 2014 Aug; 30(8):558-64. PubMed ID: 25325897
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.